NasdaqGM - Delayed Quote USD

NewAmsterdam Pharma Company N.V. (NAMS)

Compare
21.78 +2.63 (+13.73%)
At close: November 6 at 4:00 PM EST
21.78 0.00 (0.00%)
After hours: November 6 at 4:01 PM EST

Insider Purchases Last 6 Months

SharesTransactions
Purchases 56,104 4
Sales 45,000 1
Net Shares Purchased (Sold) 11,104 5
Total Insider Shares Held 234.94k --
% Net Shares Purchased (Sold) 5.00% --

Net Institutional Purchases Prior Quarter to Latest Quarter

Shares
Net Shares Purchased (Sold) --
% Change in Institutional Shares Held --

Insider Transactions Reported - Last Two Years

InsiderTransactionTypeValueDate
KOOIJ LOUISE FREDERIKA Officer Sale at price 15.72 per share. Direct 707,400 Oct 1, 2024
KOOIJ LOUISE FREDERIKA Officer -- Direct -- Sep 27, 2024
AUDET JULIETTE BERANGERE Officer Purchase at price 15.70 per share. Direct 17,333 Sep 26, 2024
DAVIDSON MICHAEL H Chief Executive Officer Purchase at price 16.27 per share. Direct 81,350 Aug 20, 2024
DAVIDSON MICHAEL H Chief Executive Officer Purchase at price 17.26 per share. Direct 86,308 Jun 20, 2024
TOPPER JAMES N Director Purchase at price 21.50 per share. Indirect 181,224 Mar 26, 2024
KASTELEIN JOHANNES JACOB PIETER M.D., PH.D. Officer and Director -- Indirect -- Mar 26, 2024
KASTELEIN JOHANNES JACOB PIETER M.D., PH.D. Officer and Director Sale at price 21.50 per share. Indirect 4,095,234 Mar 26, 2024
LANGE LOUIS G M.D., PH.D. Director Purchase at price 19.00 per share. Indirect 95,000 Feb 13, 2024
BIGHAM MICHAEL F Director Conversion of Exercise of derivative security at price 9.87 per share. Direct 296,100 Nov 22, 2022
BALTERA ROBERT F JR. Director Conversion of Exercise of derivative security at price 9.87 per share. Direct 296,100 Nov 22, 2022
POLU KRISHNA R Director Conversion of Exercise of derivative security at price 9.87 per share. Direct 296,100 Nov 22, 2022
TOPPER DAVID JOSEPH Chief Financial Officer Conversion of Exercise of derivative security at price 9.87 per share. Direct 296,100 Nov 22, 2022

Related Tickers